Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (361-370 of 583) with videos related to

Pageof 59
Sort By:
Cancer Genetics and Cytogenetics|July 15, 1989
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaC D Bloomfield, L M Secker-Walker, A I Goldman, et al.
Blood|April 10, 2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesJames W Vardiman, Jüergen Thiele, Daniel A Arber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Blood|August 30, 2003
Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignanciesBruce Poppe, Jo Vandesompele, Claudia Schoch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Blood|August 15, 1997
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular studyR E Gallagher, C L Willman, J L Slack, et al.
Cancer|October 10, 2013
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trialsWilliam G Woods, Anna R K Franklin, Todd A Alonzo, et al.
Science (New York, N.Y.)|October 16, 1999
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringT R Golub, D K Slonim, P Tamayo, et al.
Cancer Causes & Control : CCC|September 26, 2009
Low cancer incidence rates in Ohio AmishJudith A Westman, Amy K Ferketich, Ross M Kauffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2004
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genesClaudia D Baldus, Sandya Liyanarachchi, Krzysztof Mrózek, et al.
Pageof 59

Showing results (361-370 of 583) with videos related to

Sort By:
Pageof 59
Cancer Genetics and Cytogenetics|July 15, 1989
Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemiaC D Bloomfield, L M Secker-Walker, A I Goldman, et al.
Blood|April 10, 2009
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changesJames W Vardiman, Jüergen Thiele, Daniel A Arber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.
Blood|August 30, 2003
Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignanciesBruce Poppe, Jo Vandesompele, Claudia Schoch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B studyW Stock, C A Westbrook, B Peterson, et al.
Blood|August 15, 1997
Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular studyR E Gallagher, C L Willman, J L Slack, et al.
Cancer|October 10, 2013
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trialsWilliam G Woods, Anna R K Franklin, Todd A Alonzo, et al.
Science (New York, N.Y.)|October 16, 1999
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringT R Golub, D K Slonim, P Tamayo, et al.
Cancer Causes & Control : CCC|September 26, 2009
Low cancer incidence rates in Ohio AmishJudith A Westman, Amy K Ferketich, Ross M Kauffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2004
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genesClaudia D Baldus, Sandya Liyanarachchi, Krzysztof Mrózek, et al.
Pageof 59